Business Context and Reporting Period
Company: Surgery Partners, Inc. (SGRY)
Filing Type: Form 8-K (Current Report)
Date of Report: March 2, 2026
Reporting Period: Fourth quarter and full year ended December 31, 2025
This filing announces the release of financial results for the specified period via a press release (Exhibit 99.1) and an earnings presentation (Exhibit 99.2). The company is incorporated in Delaware and trades on the Nasdaq Global Select Market.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, and Liquidity: The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1) and earnings presentation (Exhibit 99.2), which are referenced but not included in the text of this 8-K summary.
Non-GAAP Measures: The company utilizes non-GAAP financial measures in its reporting, with reconciliations to GAAP measures provided in the attached press release.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to prior periods. Investors must refer to the attached exhibits for comparative analysis.
Guidance, Outlook, and Management Commentary
- Conference Call: Scheduled for March 3, 2026, at 8:30 a.m. Eastern Time to discuss Q4 and full-year 2025 results.
- Investor Resources: An earnings presentation is available on the Investor Relations section of the company website (www.surgerypartners.com) and is furnished as Exhibit 99.2.
- Legal Disclaimer: Information in this 8-K and its exhibits is "furnished" and not "filed" under Section 18 of the Securities Exchange Act of 1934, meaning it is not subject to the liabilities of that section nor incorporated by reference into Securities Act filings unless expressly stated.
Important Facts for Investor Verification
- Verify specific Q4 and full-year 2025 financial results in the attached press release (Exhibit 99.1).
- Review the reconciliation of non-GAAP to GAAP financial measures provided in the press release.
- Access the Q4 2025 Earnings Presentation (Exhibit 99.2) for detailed management commentary and outlook.
- Note the distinction that this 8-K furnishes information rather than filing it for liability purposes under Section 18.